NDAINJECTIONINJECTABLE
Approved
Feb 1981
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
TECHNETIUM TC-99M MEDRONATE KIT (technetium tc 99m medronate) by R-Pharm US is radiopharmaceutical activity [moa]. First approved in 1981.
Drug data last refreshed 3h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Technetium Tc-99m Medronate is a radioactive diagnostic agent supplied as a kit for reconstitution with pertechnetate. It is used for skeletal scintigraphy to detect areas of altered osteogenesis in bone. The radiopharmaceutical localizes to bone tissue, enabling imaging of bone metabolism and pathology.
LOE Approaching
As a mature diagnostic product approaching LOE with moderate competitive pressure (30%), the brand team is likely focused on maintenance and operational efficiency rather than growth.
Mechanism of Action
Radiopharmaceutical Activity
Pharmacologic Class:
Radioactive Diagnostic Agent
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
This product offers limited career momentum with zero linked jobs currently open. Working on a mature diagnostic radiopharmaceutical approaching LOE typically means supporting existing accounts and managing decline rather than driving innovation or growth.
Diagnostic Product ManagerField Sales Representative
Worked on TECHNETIUM TC-99M MEDRONATE KIT at R-Pharm US? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.